Krsnaa Diagnostics Limited has informed the Exchange regarding Change in Director(s) of the company.
KRSNAA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Krsnaa Diagnostics Limited's Board meeting on April 17, 2026 approved several leadership changes. Two new Independent Directors were appointed: Mr. Raju Venkatraman (founder of Medall Healthcare) and Ms. Lilian Jessie Paul (marketing strategist, PolicyBazaar board member). Mr. Chetan Desai was re-appointed for a 5-year term. Mr. Chandra Prakash Singh was appointed as Interim CFO (KMP) effective immediately. Three directors completed their tenure: Ms. Pallavi Bhatevara (Whole-time Director), Mr. Rajiva Ranjan Verma, and Ms. Chhaya Palrecha (both Independent Directors). All board committees were reconstituted effective April 25, 2026.
The appointment of an Interim CFO suggests a CFO transition mid-term, which may raise concerns about executive stability. However, the addition of experienced independent directors and committee reconstitution indicates a strengthening of governance, which could be viewed positively by shareholders.